Dr. Aubrey de Grey is a researcher and advocates in the field of aging and longevity. He is the Chief Science Officer of the SENS Research Foundation, an organization dedicated to developing therapies to repair the damage associated with aging, and a co-founder of the Methuselah Foundation, which promotes research on extending the human lifespan.
Dr. de Grey is known for his controversial ideas about the potential for humans to significantly extend their lifespan through advances in biotechnology and medicine. He has proposed a research program called “Strategies for Engineered Negligible Senescence” (SENS), which aims to develop therapies that can repair the damage that accumulates in the body over time and is thought to be a major contributor to aging and age-related diseases.
Dr. de Grey has published numerous articles on aging and longevity in scientific journals and has written several popular science books on these topics. He is also an active public speaker and has given numerous talks and lectures on aging and longevity at conferences and events around the world. Despite some criticism and skepticism from other scientists and researchers, Dr. de Grey’s ideas and work have gained a significant following among those interested in extending the human lifespan.
Table of Contents
Aubrey de Grey’s Background and Education
Dr. Aubrey de Grey is a British gerontologist and biomedical gerontologist, who received his undergraduate degree in computer science from the University of Cambridge in 1985. After working as a researcher in the field of computer science for several years, he returned to Cambridge to pursue a Ph.D. in biology.
Dr. de Grey’s doctoral research focused on the genetics of aging in yeast, and he received his Ph.D. in 2000. After completing his Ph.D., he became involved in research on aging and longevity and has since dedicated his career to studying and advocating for the potential to extend the human lifespan through advances in biotechnology and medicine.
In addition to his formal education and research experience, Dr. de Grey has also undertaken extensive self-study on aging and longevity and has read widely on these topics. He has also interacted with and learned from other researchers and experts in the field through his work with the SENS Research Foundation and the Methuselah Foundation.
Dr. Aubrey de Grey’s Research Contributions
Dr. Aubrey de Grey is known for his controversial ideas about the potential for humans to significantly extend their lifespan through advances in biotechnology and medicine. He has proposed a research program called “Strategies for Engineered Negligible Senescence” (SENS), which aims to develop therapies that can repair the damage that accumulates in the body over time and is thought to be a major contributor to aging and age-related diseases.
Dr. de Grey has identified seven categories of damage that he believes contribute to aging: DNA mutations and nuclear DNA damage, death-resistant cells, senescent cells, extracellular matrix stiffening, extracellular crosslinks, intracellular junk, and mitochondria. He has proposed specific strategies for addressing each of these categories of damage, including gene therapy, stem cell therapy, and other techniques.
Dr. de Grey has published numerous articles on aging and longevity in scientific journals and has written several popular science books on these topics. He has also given numerous talks and lectures on aging and longevity at conferences and events around the world. Despite some criticism and skepticism from other scientists and researchers, Dr. de Grey’s ideas and work have gained a significant following among those interested in extending the human lifespan.
Aubre’s Awards and Honors
Dr. Aubrey de Grey has received a number of awards and honors for his work in the field of aging and longevity. Some notable examples include:
- The Paul F. Glenn Foundation Award for Research in the Biological Mechanisms of Aging, which he received in 2006. This award is given annually to a researcher who has made significant contributions to the understanding of the biological mechanisms of aging.
- The Kurzweil Prize for Health and Longevity, which he received in 2007. This prize is awarded annually to an individual who has made significant contributions to the field of health and longevity through their research, writing, or advocacy.
- The International Longevity Alliance Lifetime Achievement Award, which he received in 2014. This award is given to individuals who have made significant contributions to the field of aging and longevity through their research, writing, or advocacy.
- The World Health Summit Award for Outstanding Contributions to Global Health, which he received in 2015. This award is given to individuals who have made significant contributions to global health through their research, writing, or advocacy.
Dr. de Grey has also received a number of other awards and honors throughout his career and has been recognized by various organizations and institutions for his contributions to the field of aging and longevity.
Popular science writing and public outreach
Dr. Aubrey de Grey is known for his popular science writing and public outreach on the topic of aging and longevity. He has written several popular science books on these topics, including “Ending Aging: The Rejuvenation Breakthroughs That Could Reverse Human Aging in Our Lifetime” and “The Mitochondrial Free Radical Theory of Aging.”
In addition to his books, Dr. de Grey has also written numerous articles on aging and longevity for popular science magazines and websites and has contributed to several edited volumes on these topics. He is known for his clear and accessible writing style and his ability to communicate complex scientific ideas to a general audience.
Dr. de Grey is also an active public speaker and has given numerous talks and lectures on aging and longevity at conferences and events around the world. He is known for his engaging and thought-provoking presentations and has a reputation for being able to explain complex scientific concepts in a way that is accessible to a general audience.
Through his popular science writing and public outreach, Dr. de Grey has helped to raise awareness about the potential for humans to extend their lifespan through advances in biotechnology and medicine and has contributed to the ongoing public conversation about aging and longevity.
Future of Aubrey de Grey’s Work
Dr. Aubrey de Grey is currently the Chief Science Officer of the SENS Research Foundation, a non-profit organization that he co-founded in 2009 to advance research on interventions that can repair the damage that accumulates in the body over time and is thought to be a major contributor to aging and age-related diseases. He is also the co-founder and Chief Science Officer of AgeX Therapeutics, a biotech company that is developing therapies based on his research on regenerative medicine and tissue engineering.
Dr. de Grey’s primary focus is on continuing to develop and advance his research program, “Strategies for Engineered Negligible Senescence” (SENS), which aims to develop therapies that can repair the damage that accumulates in the body over time and extend the human lifespan. He is also actively engaged in public outreach and advocacy efforts to promote the potential for humans to extend their lifespan through advances in biotechnology and medicine.
In the future, Dr. de Grey hopes to see significant progress in the development of therapies that can repair the damage that accumulates in the body over time and extend the human lifespan. He is optimistic that these therapies will become a reality within his lifetime, and is committed to continuing his work to make this a reality.
What Supplements Is Aubrey Taking?
Dr. Aubrey de Grey has written and spoken about various supplements and dietary interventions that he believes may have the potential to promote health and longevity. Some of the supplements and interventions that he has discussed include:
- Nicotinamide riboside (NR), is a form of vitamin B3 that has been shown to increase levels of a molecule called NAD+ in the body. NR has been shown to have a number of potential health benefits, including improving insulin sensitivity, reducing inflammation, and increasing lifespan in animal models.
- Resveratrol, a compound found in red wine and certain plants have been shown to have a number of potential health benefits, including reducing inflammation, improving insulin sensitivity, and increasing lifespan in animal models.
- Metformin, a drug that is commonly used to treat type 2 diabetes and has been shown to have a number of potential health benefits, including reducing inflammation, improving insulin sensitivity, and increasing lifespan in animal models.
- Intermittent fasting, a dietary intervention that involves restricting food intake for certain periods of time, which has been shown to have a number of potential health benefits, including reducing inflammation, improving insulin sensitivity, and increasing lifespan in animal models.
It’s important to note that the potential health benefits of these supplements and interventions are still being studied and are not yet fully understood. It is always important to consult with a healthcare provider before starting any new supplement or dietary intervention.
Dr. Aubrey de Grey and AgeX Therapeutics
Dr. Aubrey de Grey is the co-founder and Chief Science Officer of AgeX Therapeutics, a biotech company that is focused on developing therapies based on his research on regenerative medicine and tissue engineering. AgeX was founded in 2017 and is headquartered in Alameda, California.
One of the main areas of focus for AgeX is developing therapies that can stimulate the body’s own regenerative processes to repair and regenerate damaged tissue and organs. This approach, known as “regenerative rejuvenation,” is based on the idea that the aging process is caused in part by the gradual accumulation of damage to cells and tissues over time. By stimulating the body’s own regenerative processes, it may be possible to repair this damage and extend its lifespan.
AgeX is currently developing a number of therapies based on this approach, including:
- Induced Tissue Regeneration (iTR), is a technology that uses small molecules to stimulate the body’s own regenerative processes and repair damaged tissue.
- Telomerase-based therapies, use the enzyme telomerase to extend the lifespan of cells and tissues and delay the onset of age-related diseases.
- AgeX PureStem is a technology that uses stem cells to regenerate damaged tissue and organs.
In addition to its work in regenerative medicine, AgeX is also focused on developing therapies for age-related diseases, such as diabetes, cardiovascular disease, and neurodegenerative conditions.
Overall, AgeX’s goal is to develop therapies that can extend the human lifespan and improve health span, the number of years a person lives in good health.
Conclusion
Dr. de Grey’s primary focus is on developing and advancing his research program, “Strategies for Engineered Negligible Senescence” (SENS), which aims to develop therapies that can repair the damage that accumulates in the body over time and extend the human lifespan. He has written extensively on this topic and is a leading advocate for the potential for humans to extend their lifespan through advances in biotechnology and medicine.
Dr. de Grey has received numerous awards and honors for his work, including the inaugural Methuselah Mouse Prize for his contributions to the field of aging research, and the Lifeboat Foundation’s Heroes of Science award. He is also an active public speaker and has given numerous talks and lectures on aging and longevity at conferences and events around the world.